{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:57:56Z","timestamp":1788238676885,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.leukres.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T13:38:32Z","timestamp":1519997912000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Primary plasma cell leukemia in the era of novel agents for myeloma \u2013 a multicenter retrospective analysis of outcome"],"prefix":"10.1016","volume":"68","author":[{"given":"Chezi","family":"Ganzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ory","family":"Rouvio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Avivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Magen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osnat","family":"Jarchowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossi","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Tadmor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netanel A.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav","family":"Leiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Bulvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Polliack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe E.","family":"Gatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2018.02.010_bib0005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood.V52.4.839.bloodjournal524839","article-title":"Plasma cell leukemia (PCL): a report on 15 patients","volume":"52","author":"Woodruff","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.02.010_bib0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.leukres.2010.04.021","article-title":"Flow cytometric immunophenotypic characteristics of 36 cases of plasma cell leukemia","volume":"35","author":"Kraj","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2018.02.010_bib0015","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/annonc\/mdq646","article-title":"Primary plasma cell leukemia: a retrospective multicenter study of 73 patients","volume":"22","author":"Pagano","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000210555","article-title":"A retrospective analysis of thirty-one cases of plasma cell leukemia from a single center in China","volume":"121","author":"Peijing","year":"2009","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0025","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0002-9343(87)90942-9","article-title":"Plasma cell leukemia: an evaluation of response to therapy","volume":"83","author":"Noel","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.leukres.2018.02.010_bib0030","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2141.1994.tb05114.x","article-title":"Primary plasma cell leukaemia","volume":"88","author":"Dimopoulos","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0035","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood.V93.3.1032.403a15_1032_1037","article-title":"Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics","volume":"93","author":"Garcia-Sanz","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.02.010_bib0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12032-007-9011-5","article-title":"Thirty patients with primary plasma cell leukemia: a single center experience","volume":"25","author":"Colovic","year":"2008","journal-title":"Med. Oncol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/leu.2011.176","article-title":"Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience","volume":"26","author":"Avet-Loiseau","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.010_bib0050","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00277-002-0480-5","article-title":"Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia","volume":"81","author":"Vela-Ojeda","year":"2002","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0055","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2008.4","article-title":"Genetic aberrations and survival in plasma cell leukemia","volume":"22","author":"Tiedemann","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.010_bib0060","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/leu.2012.107","article-title":"Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols","volume":"26","author":"Usmani","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.010_bib0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/leu.2011.312","article-title":"Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research","volume":"26","author":"Mahindra","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.010_bib0070","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/annonc\/mdr480","article-title":"Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party","volume":"23","author":"D'Arena","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000439424","article-title":"Primary plasma cell leukemia in the era of novel agents: a multicenter study of the japanese society of myeloma","volume":"135","author":"Iriuchishima","year":"2016","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0080","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1200\/JCO.2015.63.1929","article-title":"Bortezomib, doxorubicin, cyclophosphamide, dexamethasone induction followed by stem cell transplantation for primary plasma cell leukemia: a prospective phase II study of the intergroupe francophone du myelome","volume":"34","author":"Royer","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0085","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/leu.2012.336","article-title":"Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group","volume":"27","author":"Fernandez de Larrea","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.010_bib0090","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.010_bib0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.leukres.2018.02.010_bib0100","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/sj.leu.2401211","article-title":"The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma","volume":"12","author":"Pellat-Deceunynck","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.010_bib0105","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood-2014-03-565051","article-title":"Trends in survival of patients with primary plasma cell leukemia: a population-based analysis","volume":"124","author":"Gonsalves","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.02.010_bib0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/leu.2013.241","article-title":"Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia","volume":"28","author":"Musto","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.02.010_bib0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajh.23600","article-title":"Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: analysis of the Greek myeloma study group","volume":"89","author":"Katodritou","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0120","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.66.6115","article-title":"Progress in the treatment of primary plasma cell leukemia","volume":"34","author":"Musto","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/ejh.12986","article-title":"Combination therapy incorporating Bcl-2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14)","volume":"100","author":"Gonsalves","year":"2017","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2018.02.010_bib0130","doi-asserted-by":"crossref","first-page":"17514","DOI":"10.3390\/ijms160817514","article-title":"Molecular classification and pharmacogenetics of primary plasma cell leukemia: an initial approach toward precision medicine","volume":"16","author":"Simeon","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.leukres.2018.02.010_bib0135","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3324\/haematol.2009.013334","article-title":"Primary plasma cell leukemia and autologous stem cell transplantation","volume":"95","author":"Drake","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.02.010_bib0140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/bmt.2014.270","article-title":"Interpreting outcome data in hematopoietic cell transplantation for leukemia: tackling common biases","volume":"50","author":"Ofran","year":"2015","journal-title":"Bone Marrow Transplant."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618300456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618300456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T01:04:24Z","timestamp":1570842264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618300456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":28,"alternative-id":["S0145212618300456"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.02.010","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary plasma cell leukemia in the era of novel agents for myeloma \u2013 a multicenter retrospective analysis of outcome","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}